A549 – A Model for Non-Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths in the world with non-small cell lung cancer (NSCLC) making up about 85% of all lung cancer cases. With the identification of particular tyrosine kinase mutations, such as EGFR and ALK, targeted therapies shifted the paradigm of drug discovery for NSCLC. However, emergence of drug resistance … Continue reading A549 – A Model for Non-Small Cell Lung Cancer